TY - JOUR
T1 - Reflex detection of ciprofloxacin resistance in Neisseria gonorrhoeae by use of the SpeeDx ResistancePlus GC assay
AU - Lee, Darren Y.J.
AU - Ashcroft, Melinda M.
AU - Chow, Eric P.F.
AU - Sait, Michelle
AU - De Petra, Vesna
AU - Tschaepe, Marlene
AU - Lange, Sigrid
AU - Taiaroa, George
AU - Bradshaw, Catriona S.
AU - Whiley, David M.
AU - Fairley, Christopher K.
AU - Howden, Benjamin P.
AU - Chen, Marcus Y.
AU - Pasricha, Shivani
AU - Williamson, Deborah A.
N1 - This study was supported by a Project Grant from the National Health and Medical Research Council (NHMRC) of Australia (GNT1147735 to D.A.W., M.Y.C., E.P.F.C., and C.K.F.). E.P.F.C. and D.A.W. are supported by an Australian National Health and Medical Research Council Emerging Leadership Investigator Grants (GNT1172873 and GNT1174555, respectively). C.K.F. and C.S.B. are supported by an NHMRC Leadership Investigator Grant (GNT1172900 and GNT1173361, respectively). B.P.H. is supported by an NHMRC Practitioner Fellowship (GNT1105905).
PY - 2021/4/20
Y1 - 2021/4/20
N2 - Resistance-guided therapy (RGT) for gonorrhea may reduce unnecessary use of broad-spectrum antibiotics. When reflexed from the Aptima Combo 2 assay, the ResistancePlus GC assay demonstrated 94.8% sensitivity and 100.0% specificity for Neisseria gonorrhoeae detection. Of the 379 concordant N. gonorrhoeae-positive samples, 86.8% were found to possess the gyrA S91F mutation, which was highly predictive for ciprofloxacin resistance and stable across 3,144 publicly available N. gonorrhoeae genomes. Our work supports the feasibility of implementing RGT for gonorrhea into routine molecular workflows.
AB - Resistance-guided therapy (RGT) for gonorrhea may reduce unnecessary use of broad-spectrum antibiotics. When reflexed from the Aptima Combo 2 assay, the ResistancePlus GC assay demonstrated 94.8% sensitivity and 100.0% specificity for Neisseria gonorrhoeae detection. Of the 379 concordant N. gonorrhoeae-positive samples, 86.8% were found to possess the gyrA S91F mutation, which was highly predictive for ciprofloxacin resistance and stable across 3,144 publicly available N. gonorrhoeae genomes. Our work supports the feasibility of implementing RGT for gonorrhea into routine molecular workflows.
KW - Antimicrobial resistance
KW - Molecular diagnostic
KW - Neisseria gonorrhoeae
KW - Whole-genome sequencing
U2 - 10.1128/JCM.00089-21
DO - 10.1128/JCM.00089-21
M3 - Article
C2 - 33658263
AN - SCOPUS:85105054079
SN - 0095-1137
VL - 59
JO - Journal of Clinical Microbiology
JF - Journal of Clinical Microbiology
IS - 5
M1 - e00089-21
ER -